Biomarker Testing in Non-Small Cell Lung Carcinoma: Performance and Patient Outcomes

被引：0
|
作者：
Fadel, Saleh [1 ]
Chirip, Venus [2 ]
Wheatley-Price, Paul [3 ]
Reaume, Neil [3 ]
Lo, Bryan [1 ]
Chang, Nina [4 ]
Sekhon, Harmanjatinder [4 ]
Gomes, Marcio [1 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[2] Eastern Ontario Reg Lab Assoc, Ottawa Hosp, Ottawa, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
[4] Univ Ottawa, Ottawa Hosp, Eastern Ontario Reg Lab Assoc, Ottawa, ON, Canada
来源：
LABORATORY INVESTIGATION | 2021年 / 101卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
923
引用
收藏
页码：1103 / 1104
页数：2
相关论文
共 50 条
  • [41] Cell-free tumour DNA as a diagnostic and prognostic biomarker in non-small cell lung carcinoma
    Lochowska, Barbara
    Nowak, Dariusz
    Bialasiewicz, Piotr
    ADVANCES IN RESPIRATORY MEDICINE, 2019, 87 (02) : 118 - 122
  • [42] REAL-WORLD UTILIZATION PATTERNS AND OUTCOMES OF BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER IN AN INTEGRATED HEALTHCARE SYSTEM
    Alcasid, Nathan
    Tupper, Haley I.
    Sarovar, Varada
    Dong, Huyun
    Dyer, Wendy
    Yang, Jingrong
    Patel, Ashish
    Ashiku, Simon K.
    Sakoda, Lori
    Velotta, Jeffrey B.
    CHEST, 2024, 166 (04) : 4368A - 4369A
  • [43] Collagen XXIII: A biomarker for non-small cell lung cancer
    Spivey, Kristin A.
    Banyard, Jacqueline
    Solis, Luisa M.
    Wistuba, Ignacio I.
    Barletta, Justine A.
    Gandhi, Leena
    Feldman, Henry A.
    Rodig, Scott J.
    Chirieac, Lucian R.
    Zetter, Bruce R.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [44] BIOMARKER FOR BRAIN METASTASIS OF NON-SMALL CELL LUNG CANCER
    Yang, Seung-Ho
    Yoo, Jin Young
    Cho, Deog Gon
    Kim, Hoo Kyo
    Kim, Sung Whan
    Lee, Sang Won
    NEURO-ONCOLOGY, 2010, 12 : 64 - 64
  • [45] Molecular testing in non-small cell lung cancer
    Mahmood, Bayan
    Yin, Su Lei
    Muhammad, SyedAun
    Dancey, Gairin
    Medeiros, Filomena
    LUNG CANCER, 2022, 165 : S35 - S35
  • [46] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [47] Qualitative research to evaluate perceptions around biomarker testing and patient-reported outcomes (PROs) for use in studies of non-small cell lung cancer (NSCLC)
    Horn, M. K.
    Mathias, S. D.
    Colwell, H.
    Heerdegen, A. C.
    Bevans, K.
    Li, T.
    Stevens, A.
    Sermon, J.
    Fastenau, J.
    Pierson, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S82 - S82
  • [48] Impact of lung biomarker testing on out-of-pocket costs for metastatic non-small cell lung cancer
    Gharzai, Laila A.
    Bell, Sarah
    Gupta, Divya Myadam
    Carlos, Ruth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors
    Dorantes-Heredia, Rita
    Manuel Ruiz-Morales, Jose
    Cano-Garcia, Fernando
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (04) : 401 - 412
  • [50] Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
    Karunanithi, Vijayalakshmi
    Win, Thida
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345